Prokidney to participate in the h.c. wainwright 4th annual kidney virtual conference

Winston-salem, n.c., july 09, 2025 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney” or the “company”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (ckd), today announced that senior members of the management team will be participating in the upcoming h.c. wainwright 4th annual kidney virtual conference:

PROK Ratings Summary

PROK Quant Ranking